NovoPath CEO Letter

I’d like to share with you, our valued clients, what we accomplished together in 2018. But before I do, I should mention that your continuing trust in NovoPath solutions and services is a key driver for all of us at NovoPath. Thank you!

We had many achievements this year. Of note, The University of Texas at Houston selected NovoPath to meet its increasing Anatomic Pathology lab needs. In addition, NovoPath received Frost & Sullivan’s Technology Leadership Award for 2018. On the platform side, we focused on solutions for Precision Medicine (PM), Clinical Pathology (CP), and Advanced Billing (AB) to help labs expand their services and reduce costs. We also added Optical Character Recognition support to speed up manual accessioning since printed requisitions are still commonplace.

For 2019, we will continue to expand NovoPath’s functional and technological advantages while maintaining our stellar personal service and customer care. We also plan to fine-tune the way we inform you of new and existing solutions. In fact, you may have already noticed the new look of NovoPath’s website.

Lastly, we encourage you to share your constructive feedback – it is important to us. We truly appreciate the work you do to provide excellent patient care and it gives us a great deal of satisfaction to be a part of that care delivery.


Wally Soufi Signature
Wally Soufi
Chairman & CEO